The results show elevated IL-6, IFN-γ, IL-10, and IL-2 expression levels in sCRS patients spanning from ‘ before CAR-T ‘ to ‘ peak CRS ‘, which returned to normal levels after one week post-infusion. This evidence concerns the gene IL6 and congenital rubella syndrome.